Clinical trial
A Phase 3 Study to Determine if RTB101 Prevents Clinically Symptomatic Respiratory Illness in the Elderly
NCT04668352 is registered in ClinicalTrials.gov with Restorbio Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 3 Study to Determine if RTB101 Prevents Clinically Symptomatic Respiratory Illness in the Elderly
- Lead sponsor
- Restorbio Inc.
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- April 15, 2019
- Completion date
- December 2, 2019
- Enrollment
- 1,024 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.